Clinical stage IA2 non-small cell lung cancer
Conditions
Interventions
Observation group:None
Sponsors
Huzhou Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. On lung window, the lesion presents as a T1b mixed ground-glass nodule with CTR > 0.5, where CTR is calculated as (solid component diameter in the maximum cross-section of the nodule / nodule diameter) x 100%; 2. Preoperative biopsy or intraoperative pathology confirms non-small cell lung cancer (NSCLC); 3. Clinical evaluation demonstrates negative regional lymph nodes and no distant metastasis; 4. The patient's general condition is deemed suitable for lobectomy.
Exclusion criteria
Exclusion criteria: 1. Patients with missing clinical data; 2. Patients with small cell lung cancer (SCLC); 3. Patients with a history of non-pulmonary malignancies; 4. Patients with a history of neoadjuvant therapy for tumors prior to surgery; 5. Patients with extensive calcification of peripulmonary lymph nodes that precludes systemic lymph node assessment, or those with unstable intraoperative conditions who opt out of systemic lymph node evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor biological characteristics (including pathological grading, intravascular tumor thrombus, pleural invasion, and aerogenous spread); | — |
Countries
China
Contacts
Public ContactHuangJunjun
Huzhou Center Hospital
Outcome results
None listed